Measurement of 11-Oxo-androgens, A Novel Biomarker, in Females with Clinical Signs of Premature Adrenarche
PDF

Original Article

Measurement of 11-Oxo-androgens, A Novel Biomarker, in Females with Clinical Signs of Premature Adrenarche

J Clin Res Pediatr Endocrinol 2026;18(1):42-47 DOI: 10.4274/jcrpe.galenos.2025.2025-3-20
, , , , ,
PDF
Permissions

Abstract

Objective

Endocrine findings in premature adrenarche have been characterized by elevated dehydroepiandrosterone (DHEA) DHEA-sulfate (DHEA-S) levels in the past.

Methods

We reviewed female patients, aged 4 to 8 years, with premature adrenarche who were seen at a single center between 2019 and 2023. Data were collected on the traditional androgens (DHEA and DHEA-S) and novel 11-oxo-androgens, which were measured using liquid chromatography/tandem mass spectrometry assays in commercial laboratories (Lab Corp).

Results

The study included 44 girls. The majority, 89% of patients from the youngest group (4-5 years olds), presented with apocrine odor as the only symptom of premature adrenarche. We have demonstrated that DHEA and DHEA-S levels were within the normal range in many girls with premature adrenarche, whereas 11-oxo-androgens, particularly 11-hydroxyandrostenedione and 11-beta-hydroxytestosterone, were elevated. Out of those with normal DHEA-S, 75% had elevated 11-hydroxyandrostenedione, and 77.8% of those patients with normal DHEA had the same elevated oxo-androgen. Moreover, advanced bone age greater than 1 year compared to chronological age was positively associated with 11-ketotestosterone [Spearman rho=0.32, 95% confidence interval (CI): 0.01-0.57, p=0.0429] and 11β-hydroxy testosterone (Spearman rho=0.32, 95% CI: 0.01-0.58, p=0.0395).

Conclusion

We propose that 11-oxo-androgens are a more sensitive steroid to be measured when premature adrenarche is suspected.

Keywords: Oxo-androgens, adrenarche, child, premature

Graphical Abstract

Read the full text

5 sections · 2 figures · 3 tables · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Novello L, Speiser PW. Premature adrenarche. Pediatr Ann. 2018;47:e7-e11.

2

Saenger P, Dimartino-Nardi J. Premature adrenarche. J Endocrinol Invest. 2001;24:724-733.

3

Ibáñez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev. 2000;21:671-696.

4

Cutler GB Jr, Loriaux DL. Andrenarche and its relationship to the onset of puberty. Fed Proc. 1980;39:2384-2390.

5

Silverman Sh, Migeon C, Rosemberg E, Wilkins L. Precocious growth of sexual hair without other secondary sexual development; premature pubarche, a constitutional variation of adolescence. Pediatrics. 1952;10:426-432.

6

Rosenfield RL. Normal and premature adrenarche. Endocr Rev. 2021;42:783-814.

7

Smail PJ, Faiman C, Hobson WC, Fuller GB, Winter JS. Further studies on adrenarche in nonhuman primates. Endocrinology. 1982;111:844-848.

8

Rege J, Turcu AF, Kasa-Vubu JZ, Lerario AM, Auchus GC, Auchus RJ, Smith JM, White PC, Rainey WE. 11-ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche. J Clin Endocrinol Metab. 2018;103:4589-4598.

9

Turcu AF, Nanba AT, Auchus RJ. The rise, fall, and resurrection of 11-oxygenated androgens in human physiology and disease. Horm Res Paediatr. 2018;89:284-291. Epub 2018 May 9

10

Rege J, Nakamura Y, Satoh F, Morimoto R, Kennedy MR, Layman LC, Honma S, Sasano H, Rainey WE. Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. J Clin Endocrinol Metab. 2013;98:1182-1188. Epub 2013 Feb 5

11

Stanczyk FZ, Chang L, Carmina E, Putz Z, Lobo RA. Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate? Am J Obstet Gynecol. 1991;165:1837-1842.

12

Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, Arai Y, Suzuki T, Sasano H, Ishibashi T, Ito S. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res. 2007;30:1083-1095.

13

Nakamura Y, Rege J, Satoh F, Morimoto R, Kennedy MR, Ahlem CN, Honma S, Sasano H, Rainey WE. Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein corticosteroids before and after adrenocorticotropic hormone stimulation. Clin Endocrinol (Oxf). 2012;76:778-784.

14

O’Reilly MW, Kempegowda P, Jenkinson C, Taylor AE, Quanson JL, Storbeck KH, Arlt W. 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102:840-848.

15

Taylor AE, Ware MA, Breslow E, Pyle L, Severn C, Nadeau KJ, Chan CL, Kelsey MM, Cree-Green M. 11-oxyandrogens in adolescents with polycystic ovary syndrome. J Endocr Soc. 2022;6:bvac037.

16

Korth-Schutz S, Levine LS, New MI. Serum androgens in normal prepubertal and pubertal children and in children with precocious adrenarche. J Clin Endocrinol Metab. 1976;42:117-124.

17

Ducharme JR, Forest MG, De Peretti E, Sempé M, Collu R, Bertrand J. Plasma adrenal and gonadal sex steroids in human pubertal development. J Clin Endocrinol Metab. 1976;42:468-476.

18

Arlt W. CAHtalyzing change in congenital adrenal hyperplasia. N Engl J Med. 2024;391:559-561.

19

Rosenfield RL. Normal and premature adrenarche. Endocr Rev. 2021;42:783-814.